|
Dr. Nissenson is professor of medicine and director of the Dialysis Program at University of California at Los Angeles (UCLA). He is the past president of the Renal Physicians Association, a world-renowned nephrologist, and a leader in kidney medicine and EPO development. He also advises Amgen Inc. (AMGN-NASDAQ) and Baxter International, Inc. (BAX-NYSE). | 